We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
표시할 이벤트가 없습니다.
Consensus vs. actual, and revenue trend
| 분기 | 발표일 | 시각 | EPS 예상 | EPS 실제 | 서프라이즈 | 매출 예상 | 매출 실제 | 상태 |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 15. | 장 마감 후 (AMC) | — | — | — | — | — | 예정 |
| FY2026 Q3 | 2026. 03. 31. | 시각 미정 | — | $-3.18 | — | — | $20.94K | 보고됨 |
| FY2018 Q3 | 2018. 03. 31. | 시각 미정 | — | — | — | — | $0 |
Rating & price-target changes
표시할 리서치 액션이 없습니다.
동일 리서치펌의 과거 의견 변화, 동일 섹터 내 다른 종목 액션과 비교 가능
| FY2016 Q3 | 2016. 03. 31. | 시각 미정 | — | — | — | — | $42.53K | 보고됨 |
공시·실적·기관 변화를 한국어 한 단락으로 요약. 원문 출처와 함께 제공됩니다.
Ranked by position value
표시할 보유 데이터가 없습니다.
신규 편입·전량 매도·비중 변화까지 모두 확인할 수 있습니다.
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.
Stored first · Google News · Yahoo Finance (English)
LNAI Stock Chart | LUNAI BIOWORKS INC (NASDAQ:LNAI) - ChartMill
LNAI Stock Chart | LUNAI BIOWORKS INC (NASDAQ:LNAI) ChartMill
Lunai Bioworks and BrainStorm Therapeutics Partner to Advance Drug Discovery for Parkinson’s and Rare Epilepsy with Foundation Funding - geneonline.com
Lunai Bioworks and BrainStorm Therapeutics Partner to Advance Drug Discovery for Parkinson’s and Rare Epilepsy with Foundation Funding geneonline.com
Lunai Bioworks Inc. and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's And Rare Epilepsy AI Discovery Collaboration - marketscreener.com
Lunai Bioworks Inc. and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's And Rare Epilepsy AI Discovery Collaboration marketscreener.com
Lunai Bioworks and BrainStorm Therapeutics partner to advance AI-driven neurology drug discovery. - Pluang
Lunai Bioworks and BrainStorm Therapeutics partner to advance AI-driven neurology drug discovery. Pluang
Lunai Bioworks partners with BrainStorm on neurology drug discovery By Investing.com - Investing.com Nigeria
Lunai Bioworks partners with BrainStorm on neurology drug discovery By Investing.com Investing.com Nigeria
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration - PR Newswire
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration PR Newswire